Double-blind, randomized, clinical trial of metformin as add-on treatment with clozapine in treatment of schizophrenia disorder

BACKGROUND: One of the major causes of death in schizophrenia is a metabolic syndrome. The clozapine has the highest rate of weight gain among antipsychotics. It has been shown that metformin can promote weight loss. We aimed to investigate the effect of metformin as an adjunctive therapy with cloza...

Descripción completa

Detalles Bibliográficos
Autores principales: Hebrani, Paria, Manteghi, Ali Akhoundpour, Behdani, Fatemeh, Hessami, Elham, Rezayat, Kambiz Akhavan, Marvast, Majid Nabizadeh, Rezayat, Amir Akhavan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468452/
https://www.ncbi.nlm.nih.gov/pubmed/26109992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468452/
https://www.ncbi.nlm.nih.gov/pubmed/26109992

Ejemplares similares